Incidence of Skin Hyperpigmentation in Black Patients Receiving Treatment with Immunomodulatory Drugs.
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood.2021010853
Abstract: In a retrospective single-center review of patients with myeloma treated with the immunomodulatory drug thalidomide, lenalidomide, or pomalidomide, the authors report that marked hyperpigmentation occurred in 40% of Black patients, compared with 3.5% of White… read more here.
Keywords: black patients; skin hyperpigmentation; patients receiving; hyperpigmentation ... See more keywords